Obesity hypoventilation syndrome
Obesity Hypoventilation Syndrome (OHS)[edit | edit source]
Overview[edit | edit source]
Obesity Hypoventilation Syndrome (OHS), also known as Pickwickian Syndrome, is a respiratory disorder primarily affecting individuals with significant obesity. It is characterized by inadequate ventilation in obese individuals, leading to low oxygen levels (hypoxemia) and elevated carbon dioxide (CO2) levels (hypercapnia) in the blood.
Pathophysiology[edit | edit source]
Mechanism[edit | edit source]
OHS results from a combination of factors related to obesity, including mechanical effects on the lungs and chest wall, decreased respiratory drive, and hormonal disturbances. The excess weight on the chest and abdomen hinders the normal expansion of the lungs and diaphragm, leading to hypoventilation.
Association with Sleep Disorders[edit | edit source]
OHS is closely associated with Obstructive Sleep Apnea (OSA) - a condition where excessive fat deposits around the upper airway cause intermittent obstruction during sleep. However, OHS can occur independently of OSA.
Clinical Features[edit | edit source]
Symptoms[edit | edit source]
- Daytime sleepiness
- Fatigue
- Shortness of breath
- Snoring
- Headaches (especially in the morning)
Complications[edit | edit source]
- Pulmonary hypertension
- Right heart failure (cor pulmonale)
- Secondary erythrocytosis
Diagnosis[edit | edit source]
Diagnosis involves a combination of clinical evaluation and tests such as:
- Polysomnography (sleep study)
- Arterial blood gas analysis
- Pulmonary function tests
- Echocardiogram
Treatment[edit | edit source]
Lifestyle Changes[edit | edit source]
- Weight loss
- Regular exercise
- Dietary modifications
Medical Management[edit | edit source]
- Continuous Positive Airway Pressure (CPAP) or Bi-level Positive Airway Pressure (BiPAP) therapy
- Oxygen supplementation
- Medications to treat associated conditions
References[edit | edit source]
Prognosis[edit | edit source]
With appropriate treatment, the symptoms and complications of obesity hypoventilation syndrome can be managed effectively. Weight loss, in particular, has been shown to improve both respiratory function and overall health outcomes.
Epidemiology[edit | edit source]
The prevalence of obesity hypoventilation syndrome is increasing, paralleling the rise in obesity rates worldwide. OHS is more common in individuals with a body mass index (BMI) of 40 or higher and is often seen in conjunction with obstructive sleep apnea.
See also[edit | edit source]
- Obstructive sleep apnea
- Hypoventilation
- Sleep disorders
- Body Mass Index (BMI)
- Respiratory Failure
- Sleep Medicine
External links[edit | edit source]
- American Thoracic Society: Clinical Guideline on Obesity Hypoventilation Syndrome
- National Sleep Foundation: Obesity Hypoventilation Syndrome+
- World Health Organization
- American Lung Association
Summary[edit | edit source]
Obesity hypoventilation syndrome (OHS) is a condition in which severely overweight people fail to breathe rapidly or deeply enough, resulting in low oxygen levels and high blood carbon dioxide (CO2) levels. The syndrome is often associated with obstructive sleep apnea (OSA), which causes periods of absent or reduced breathing in sleep, resulting in many partial awakenings during the night and sleepiness during the day. The disease puts strain on the heart, which may lead to heart failure and leg swelling.
Obesity hypoventilation syndrome Resources | |
---|---|
|
Transform Your Life with W8MD Weight Loss Centers[edit source]
W8MD offers a physician-supervised weight loss program at various locations including New York, Pennsylvania and New Jersey. Our centers provide expert medical guidance, accept most insurances, and offer telemedicine options for convenience.
Why choose W8MD?[edit source]
- Comprehensive care with FDA-approved medications including:
- Weight loss injections both generic and brand names:
- Weight loss medications including Phentermine, Qsymia, Contrave, Diethylpropion etc.
- Accept most insurances for visits or discounted self pay cost.
- Generic weight loss injections starting from just $125.00 for the starting dose
- In person weight loss NYC and telemedicine medical weight loss options in New York city available
Book Your Appointment[edit source]
Start your weight loss journey today at our centers in New York, New Jersey and Pennsylvania and visit W8MD.com Call (718)946-5500
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen